Pfizer's Says Company "Very" Big Balance Sheet for Deals
Pfizer signals it can bankroll ambitious deals with a robust balance sheet. This article weighs what a 'very big' bal...
A concise guide to planning Social Security timing from a 30s perspective, covering factors that affect when to start and how it influences lifetime benefits.
20,311 articlesPfizer signals it can bankroll ambitious deals with a robust balance sheet. This article weighs what a 'very big' bal...
Tesla's delivery numbers blew past expectations, but the market reaction surprised many investors. This article break...
Off the field, Haaland maps a broader financial playbook, backing chess events, an investment firm, and a film role a...
As year-to-date markets swing, Disney and PayPal stand out as potential rebound plays. This article weighs dividends,...
OpenAI’s CFO unveils a four-question framework to assess whether AI spending actually delivers value. The approach fo...
Hollywood’s push to protect voice identity heats up as AI tools advance. Matthew McConaughey is leading a wave of tra...
Today’s gain in Viking Therapeutics stock more has traders buzzing, but the move isn’t tied to a single headline. Thi...
Retail investors are increasingly offered access to private-market products as Wall Street courts Main Street. But ex...
Sam Altman declined interview requests for a high-profile AI documentary. The director answered by creating a Sam Bot...
As the 10-year Treasury sits in the low- to mid-4% zone, select dividend stocks more than keep pace with bond returns...
A landmark view from a high-profile venture capitalist signals a shift in career guidance as AI reshapes the job mark...
Investors are watching nextnav (nn) 2025 earnings to see if the company can turn its positioning tech into steady pro...